[go: up one dir, main page]

DK0590150T3 - (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat - Google Patents

(-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Info

Publication number
DK0590150T3
DK0590150T3 DK92909279T DK92909279T DK0590150T3 DK 0590150 T3 DK0590150 T3 DK 0590150T3 DK 92909279 T DK92909279 T DK 92909279T DK 92909279 T DK92909279 T DK 92909279T DK 0590150 T3 DK0590150 T3 DK 0590150T3
Authority
DK
Denmark
Prior art keywords
azaspiro
oxa
decane
tartrate
methylene
Prior art date
Application number
DK92909279T
Other languages
English (en)
Inventor
Shin-Ichi - - Kasuga Tsukamoto
Takeru Sumitomojuutak Kohinata
Mitsuo - Kanbeeshinden I Fujii
Sakiko - Asahigaokama Tomizawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of DK0590150T3 publication Critical patent/DK0590150T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92909279T 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat DK0590150T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13961991 1991-05-15
PCT/JP1992/000548 WO1992020683A1 (fr) 1991-05-15 1992-04-27 L-tartrate de (-)-(s)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decane

Publications (1)

Publication Number Publication Date
DK0590150T3 true DK0590150T3 (da) 1999-04-19

Family

ID=15249510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909279T DK0590150T3 (da) 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Country Status (11)

Country Link
US (1) US5403931A (da)
EP (1) EP0590150B1 (da)
AT (1) ATE168114T1 (da)
AU (1) AU1666392A (da)
CA (1) CA2109117A1 (da)
DE (1) DE69226187T2 (da)
DK (1) DK0590150T3 (da)
ES (1) ES2118814T3 (da)
GR (1) GR3027686T3 (da)
RU (1) RU2057132C1 (da)
WO (1) WO1992020683A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69422182T2 (de) * 1993-08-19 2000-06-21 Merck & Co., Inc. Thermodynamisch stabile kristallform von 4"-deoxy-4"-epi-methylamino avermectin bia/bib benzoesauresalz und verfahren zu seiner herstellung
CA2326117A1 (en) * 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
JP2003063964A (ja) * 2001-08-28 2003-03-05 Senju Pharmaceut Co Ltd ドライアイまたはドライアイを伴なう疾病の予防治療剤
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US20090082381A1 (en) * 2005-07-26 2009-03-26 Akiharu Isowaki Percutaneously Absorbable Ophthalmic Preparation
CA2620333A1 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CN102361876B (zh) * 2009-01-26 2015-02-04 以色列生物研究所 二环杂环螺环化合物
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074441T3 (es) * 1987-10-05 1995-09-16 Yamanouchi Pharma Co Ltd Compuestos espiro heterociclicos y su preparacion.
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives

Also Published As

Publication number Publication date
WO1992020683A1 (fr) 1992-11-26
DE69226187T2 (de) 1998-10-22
EP0590150A1 (en) 1994-04-06
DE69226187D1 (de) 1998-08-13
CA2109117A1 (en) 1992-11-16
US5403931A (en) 1995-04-04
GR3027686T3 (en) 1998-11-30
ES2118814T3 (es) 1998-10-01
ATE168114T1 (de) 1998-07-15
RU2057132C1 (ru) 1996-03-27
EP0590150A4 (en) 1994-06-29
AU1666392A (en) 1992-12-30
EP0590150B1 (en) 1998-07-08

Similar Documents

Publication Publication Date Title
DK0590150T3 (da) (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
NO2002009I2 (no) Tiotropium
ATE141913T1 (de) Organische salze von n, n'-diacetylcystin
ATE50493T1 (de) Ibuprofen enthaltendes arzneimittel.
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
GR3020717T3 (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
DE68915653D1 (de) Organosiloxan-Olefin-Copolymere.
DE69109021D1 (de) Augentropfenarzneimittel.
FI911763A7 (fi) N5-metyyli-5,6,7,8-tetrahydrofoolihapon ammoniumsuolat
RU93058306A (ru) Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
ATE92759T1 (de) Carboplatinzusammensetzung.
NO301767B1 (no) Salt av clavulansyre
DE69033442D1 (de) Optisch aktive Verbindungen mit mehreren chiralen Zentren und ihre Herstellung
NO179504C (no) Legemiddel i form av en tablett inneholdende diritromycin
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
FR2649116B1 (fr) Composition organopolysiloxane monocomposante a stabilite au stockage amelioree
DE3681856D1 (de) Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung.
ITVE910013A0 (it) Progetto di catamarano da competizione formula o.p.1. a stabilita' idrodinamica indotta
GR3031294T3 (en) Optically active 1,4-Dihydropyridine derivatives and methods of producing the same
FI921069A0 (fi) Foerfarande foer diastereoselektiv reduktiv pinakolkoppling av homokirala a-aminoaldehyder.
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
ATE104986T1 (de) Aminsalze von 1,4,2-oxazaphospholidin-2-alkoxy-2oxid-4-essigs|uren.
PL298827A1 (en) Novel enantiomers derivatives of (s)-2-amino(3,4-dichlorobenzyl) propanol-1